Machado, Ana Rita Thomazela 
; Tuttis, Katiuska ; Santos, Patrick Wellington da Silva dos; Aissa, Alexandre Ferro; Antunes, Lusânia Maria Greggi
Fonte: Pharmaceutics. Unidades: FMRP, FCFRP
Assuntos: DANO AO DNA, NEOPLASIAS HEPÁTICAS, NUTRIGENÔMICA, SUPLEMENTOS DIETÉTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Ana Rita Thomazela et al. Diallyl disulfide induces chemosensitization to sorafenib, autophagy, and cell cycle arrest and inhibits invasion in hepatocellular carcinoma. Pharmaceutics, v. 14, n. 12, p. 1-18, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14122582. Acesso em: 02 nov. 2024.APA
Machado, A. R. T., Tuttis, K., Santos, P. W. da S. dos, Aissa, A. F., & Antunes, L. M. G. (2022). Diallyl disulfide induces chemosensitization to sorafenib, autophagy, and cell cycle arrest and inhibits invasion in hepatocellular carcinoma. Pharmaceutics, 14( 12), 1-18. doi:10.3390/pharmaceutics14122582NLM
Machado ART, Tuttis K, Santos PW da S dos, Aissa AF, Antunes LMG. Diallyl disulfide induces chemosensitization to sorafenib, autophagy, and cell cycle arrest and inhibits invasion in hepatocellular carcinoma [Internet]. Pharmaceutics. 2022 ; 14( 12): 1-18.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/pharmaceutics14122582Vancouver
Machado ART, Tuttis K, Santos PW da S dos, Aissa AF, Antunes LMG. Diallyl disulfide induces chemosensitization to sorafenib, autophagy, and cell cycle arrest and inhibits invasion in hepatocellular carcinoma [Internet]. Pharmaceutics. 2022 ; 14( 12): 1-18.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/pharmaceutics14122582
